JC VIRUS INFECTION
Clinical trials for JC VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new JC VIRUS INFECTION trials appear
Sign up with your email to follow new studies for JC VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor immune cells take on dangerous viruses in cancer patients
Disease control Recruiting nowThis study tests whether specially grown donor immune cells (called cytotoxic T lymphocytes) can safely and effectively treat BK and JC virus infections in 100 people with cancer, HIV/AIDS, or organ transplants. These viruses can cause serious problems like kidney damage or brain…
Matched conditions: JC VIRUS INFECTION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:45 UTC
-
Engineered immune cells take on viruses in cancer patients
Disease control Recruiting nowThis early-stage trial tests whether specially designed immune cells (T-cells) can safely control viral infections like CMV, BK virus, or COVID-19 in cancer patients with weakened immune systems. The cells are modified to resist common anti-rejection drugs and target specific vir…
Matched conditions: JC VIRUS INFECTION
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC